Opsidio
Bryn Mawr, US · Delaware LLC · 1 known investors
Find your way into Opsidio
Sign up to see every warm intro you have to Opsidio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Opsidio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
MD
Martin D. PhillipsNamed on SEC filing
NW
Nicholas W. LukacsNamed on SEC filing
FM
Frank MarcouxNamed on SEC filing
AE
Alan E. CasnoffNamed on SEC filing
Investors · 1
BioAdvancelisted by BioAdvanceConshohocken · $500K – $1.5M
How we know: BioAdvance's portfolio page · a partner's Signal profile · funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$800.2K disclosed across 1 round · 2017
▶$800.2KraisedOct 2017 · 4 investors · BiotechnologyRule 506(b)
▶$800.2KraisedOct 2017 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Martin D. PhillipsExecutive Officer, Director
- Nicholas W. LukacsDirector
- Frank MarcouxDirector
- Alan E. CasnoffDirector
- Offering amount
- $1.2M
- Amount sold
- $800.2K
- First sale
- Sep 2017
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Opsidio's investors?
- Opsidio's investors include BioAdvance.
- How much funding has Opsidio raised?
- Opsidio has disclosed $800.2K raised across 1 round.
- Where is Opsidio headquartered?
- Opsidio is headquartered in Bryn Mawr, US.
